Page last updated: 2024-09-03

caprylates and Neurodegenerative Diseases

caprylates has been researched along with Neurodegenerative Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Reiser, G; Schönfeld, P	1
Shah, S; Tear, S	1

Other Studies

2 other study(ies) available for caprylates and Neurodegenerative Diseases

Article	Year
Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:3 Topics: Animals; Brain; Caprylates; Carnitine; Energy Metabolism; Homeostasis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Rats	2017
Progressive neurodegenerative disease and pain. IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:12 Topics: Analgesics; Animals; Caprylates; Cognition Disorders; Egtazic Acid; Humans; Neurodegenerative Diseases; Pain; Parkinson Disease; TRPV Cation Channels	2005

Article

Year

Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:3

Topics: Animals; Brain; Caprylates; Carnitine; Energy Metabolism; Homeostasis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Rats

2017

Progressive neurodegenerative disease and pain.

IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:12

Topics: Analgesics; Animals; Caprylates; Cognition Disorders; Egtazic Acid; Humans; Neurodegenerative Diseases; Pain; Parkinson Disease; TRPV Cation Channels

2005